(Q40811162)

23 September 2017

1 reference

title

MEGX test in hepatology: the long-sought ultimate quantitative liver function test? (English)

1 reference

23 September 2017

J Reichen

1

1 reference

23 September 2017

1 August 1993

1 reference

23 September 2017

Journal of Hepatology

1 reference

23 September 2017

19

1 reference

23 September 2017

1

1 reference

23 September 2017

4-7

1 reference

Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests.

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Prognostic value of indocyanine green and lidocaine kinetics for survival and chronic hepatic encephalopathy in cirrhotic patients following elective end-to-side portacaval shunt.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Lignocaine metabolite formation as a measure of pre-transplant liver function.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Assessment of pretransplant prognosis in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Assessment of lidocaine metabolite formation as a quantitative liver function test in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Monoethylglycinexylide formation in assessing pediatric donor liver function

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Clinical Pharmacokinetics of Lignocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Commentary: a physiological approach to hepatic drug clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Determinants of drug disposition in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Severity of cirrhosis and the relationship of alpha 1-acid glycoprotein concentration to plasma protein binding of lidocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

Anaphylactoid reactions after indocyanine-green administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980169-2

7 January 2021

10.1016/S0168-8278(05)80169-2

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

8301041